SEC 13F Intelligence

Managers / Q1 2021 · view latest →

Lion Point Capital, LP

CIK 0001643354 · 375 PARK AVE, SUITE 2609, NEW YORK, NY, 10152 · 212-356-6200

Reported Value
$550M
Q1 2021
Positions
30
Filings on Record
31
2019–present window
Filed
May 19, 2021
amendment (RESTATEMENT)

Summary

Lion Point Capital, LP reported $550M in U.S.-listed holdings across 30 positions for Q1 2021.

Its largest position, Marinus Pharmaceuticals, represents 10.2% of the portfolio.

Compared with Q4 2020, the fund opened 9 new positions and exited 3.

Portfolio Metrics

Turnover
+36.8%
vs prior filed quarter
Top-10 Concentration
+59.5%
share of reported value
Largest Position
+10.2%
Marinus Pharmaceuticals
New / Exited
9 / 3
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $636MQ4 ’18Q1 ’19: $1.1BQ2 ’19: $1.0BQ3 ’19: $897MQ4 ’19: $1.1BQ4 ’19Q1 ’20: $379MQ2 ’20: $412MQ3 ’20: $456MQ4 ’20: $519MQ4 ’20Q1 ’21: $550MQ2 ’21: $579MQ3 ’21: $533MQ4 ’21: $373MQ4 ’21Q1 ’22: $431MQ2 ’22: $878MQ3 ’22: $454MQ4 ’22: $703MQ4 ’22Q1 ’23: $243MQ2 ’23: $221MQ3 ’23: $224MQ4 ’23: $200MQ4 ’23Q1 ’24: $179MQ2 ’24: $55MQ3 ’24: $45MQ4 ’24: $19MQ4 ’24Q1 ’25: $16MQ2 ’25: $15MQ3 ’25: $18MQ4 ’25: $19MQ4 ’25Q1 ’26: $17Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 58.7%ETP: 24.1%Other: 17.1%
  • Common Stock · 58.7% · $323M
  • ETP · 24.1% · $133M
  • Other · 17.1% · $94M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2020 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ISHARES TRNEW+600.0K600.0K+$133M$133M
FEFIRSTENERGY CORPNEW+700.0K700.0K+$24M$24M
COMPUTE HEALTH ACQUISITIN CONEW+1.49M1.49M+$15M$15M
JAWS MUSTANG ACQUISITION CORNEW+800.0K800.0K+$8M$8M
CC NEUBERGER PRINCIPAL HOLDNNEW+800.0K800.0K+$8M$8M
EXTRACTION OIL & GAS INCNEW+181.1K181.1K+$7M$7M
COLLECTIVE GROWTH CORPNEW+400.0K400.0K+$4M$4M
ARTIUS ACQUISITION INCNEW+100.0K100.0K+$1M$1M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2021

27 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1MARINUS PHARMACEUTICALS INCCOM NEW10.19%$56M3.62M
20LSBURGERFI INTERNATIONAL INChistory →COM7.70%$42M2.75M
3ARCONIC CORPORATIONCOM6.09%$33M1.32M
4LIBERTY GLOBAL PLCSHS CL A · SHS CL C5.95%$33M1.27M
5CSIQCANADIAN SOLAR INChistory →COM5.92%$33M656.0K
6SWCHFSIERRA WIRELESS INChistory →COM5.76%$32M2.14M
7DRRXEURDURECT CORPhistory →COM5.51%$30M15.31M
8TGTXTG THERAPEUTICS INChistory →COM5.34%$29M609.1K
9FEFIRSTENERGY CORPhistory →COM4.42%$24M700.0K
10COMPUTE HEALTH ACQUISITIN COUNIT 99/99/99992.74%$15M1.49M
11BATLHALCON RES CORPhistory →COM NEW1.85%$10M936.0K
121T7TRICIDA INChistory →COM1.76%$10M1.83M
13KINIKSA PHARMACEUTICALS LTDCOM CL A1.67%$9M495.7K
14JAWS MUSTANG ACQUISITION CORUNIT 99/99/99991.48%$8M800.0K
15CC NEUBERGER PRINCIPAL HOLDNUNIT 99/99/99991.45%$8M800.0K
16EXTREXTREME NETWORKS INChistory →COM1.29%$7M811.8K
17EXTRACTION OIL & GAS INCCOM1.18%$7M181.1K
18LUMOS PHARMA INCCOM0.87%$5M407.2K
19COLLECTIVE GROWTH CORPCOM CL A0.70%$4M400.0K
20LOGCUSDLOGICBIO THERAPEUTICS INCCOM0.66%$4M500.0K
21NXTCEURNEXTCURE INCCOM0.55%$3M300.0K
22AGLEUSDAEGLEA BIOTHERAPEUTICS INCCOM0.43%$2M300.0K
23OVVOVINTIV INCCOM0.39%$2M90.1K
24OUTFRONT MEDIA INCCOM0.30%$2M75.0K
25ARTIUS ACQUISITION INCCOM CL A0.18%$1M100.0K
26AAALCOA CORPCOM0.01%$32,0001.0K
27SCOR1EURCOMSCORE INCCOM0.00%$3,0001.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$17M35May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$19M39Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$18M27Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$15M19Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$16M21May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$19M19Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$45M25Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$55M27Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$179M32May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$200M30Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$224M31Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$221M30Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$243M31May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$703M32Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$454M41Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$878M40Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$431M35May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$373M33Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$533M38Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$579M34Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$550M30May 19, 2021RESTATEMENTchanges · EDGAR ↗
Q4 2020$519M24Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$456M24Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$412M24Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$379M25May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.1B26Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$897M26Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.0B24Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.1B24May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$636M35Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.